GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » ROE % Adjusted to Book Value

Biomind Labs (NEOE:BMND) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs ROE % Adjusted to Book Value?

Biomind Labs's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Biomind Labs's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Biomind Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.


Biomind Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Biomind Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs ROE % Adjusted to Book Value Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
-5.40 - -

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biomind Labs's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biomind Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomind Labs's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biomind Labs's ROE % Adjusted to Book Value falls into.



Biomind Labs ROE % Adjusted to Book Value Calculation

Biomind Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Biomind Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomind Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biomind Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs Headlines

No Headlines